For its fourth fiscal quarter (ending December 31), AbbVie Inc (NYSE: ABBV) has reported a -104% decline in E.P.S. from $0.46 a year ago to $-0.02 in the current quarter. For the latest four quarters through December 31, E.P.S. were $2.39 compared to $2.73 a year ago — a decline of -12%.
Recent Price Action
AbbVie Inc (NYSE: ABBV) stock closed at $183.90 on 1/31/25 after a large increase of 4.7%. Moreover, unusually high trading volume at 198% of normal accompanied the advance. The stock has risen 7.8% during the last week and has performed in line with the market over the last nine months.
Current PriceTarget Research Rating
AbbVie has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. AbbVie has a neutral Power Rating of 53 and a neutral Appreciation Score of 53, and the Neutral Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment